Longevity medicine is a fast-evolving field and it is currently outpacing the ability of the medical practice to internalize and implement the progress of related research.
Modern advances in AI and machine learning, biomarker research and drug development have produced numerous tools for early diagnostics and prevention, which remain unknown to the global medical community. The paradigm of longevity and healthy aging as the top priority will undoubtedly greatly impact the primary, secondary and tertiary prevention rates. The Longevity Medicine 101 and 201 Courses are a pivotal curriculum that provides medical professionals with most recent advances in biogerontology, geroscience and precision medicine, while teaching the ways to implement this knowledge in the clinical practice.
The curriculum has been developed by interdisciplinary experts (physicians, academic biogerontologists, AI-experts, computer scientists, KOL in longevity), covering the necessary foundation and most recent scientific evidence.
This translational medicine course allowed over 5000 physicians so far to get certified and to gain the fundamentals in the field, including theories of aging, biomarkers of aging, molecular mechanisms, and geroprotector regimens. Courses such as this course serve to close the detrimental knowledge gap and provide an overview of clinical applications of recent advances in aging research, skills to evaluate the validity of biomarkers of aging and other biological age testing systems, and knowledge of the available longevity therapies to tackle diseases related to senescence-related processes in the organisms. It implies bridging biogerontology, machine learning, differential diagnosis, omics, geroprotective interventions, drug design, and health-care organisations informing advances in these research areas while giving examples of their implementation into clinical practice.